Gotham Asset Management LLC Purchases Shares of 66,152 Bausch Health Companies Inc. (NYSE:BHC)

Gotham Asset Management LLC purchased a new stake in Bausch Health Companies Inc. (NYSE:BHC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 66,152 shares of the company's stock, valued at approximately $533,000.

A number of other hedge funds also recently bought and sold shares of BHC. Mountain Hill Investment Partners Corp. acquired a new stake in Bausch Health Companies in the 4th quarter valued at about $56,000. Bank of Nova Scotia acquired a new stake in shares of Bausch Health Companies during the 4th quarter worth about $83,000. One68 Global Capital LLC acquired a new stake in shares of Bausch Health Companies during the 4th quarter worth about $90,000. Balyasny Asset Management L.P. acquired a new stake in shares of Bausch Health Companies during the 4th quarter worth about $97,000. Finally, Alpine Global Management LLC acquired a new stake in shares of Bausch Health Companies during the 4th quarter worth about $114,000. Institutional investors and hedge funds own 78.65% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. StockNews.com downgraded Bausch Health Companies from a "buy" rating to a "hold" rating in a research note on Saturday, May 10th. Jefferies Financial Group restated a "hold" rating and set a $8.00 price target (down previously from $12.00) on shares of Bausch Health Companies in a research note on Thursday, February 6th. Finally, Royal Bank of Canada raised their price target on Bausch Health Companies from $8.50 to $10.00 and gave the stock a "sector perform" rating in a research note on Friday, May 2nd. One investment analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company's stock. Based on data from MarketBeat, Bausch Health Companies has a consensus rating of "Hold" and an average price target of $7.42.

Bausch Health Companies Trading Down 0.6%

NYSE:BHC opened at $4.64 on Tuesday. The firm has a market cap of $1.68 billion, a P/E ratio of -38.66, a PEG ratio of 0.37 and a beta of 0.34. The stock's 50 day simple moving average is $5.50 and its 200-day simple moving average is $6.92. Bausch Health Companies Inc. has a 12-month low of $3.96 and a 12-month high of $9.85.

Bausch Health Companies (NYSE:BHC - Get Free Report) last released its earnings results on Wednesday, February 19th. The company reported $1.21 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.65 by ($0.44). The company had revenue of $2.56 billion during the quarter, compared to analyst estimates of $2.51 billion. Bausch Health Companies had a negative net margin of 0.48% and a negative return on equity of 577.82%. Research analysts forecast that Bausch Health Companies Inc. will post 4.41 EPS for the current fiscal year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.